Introduction G. sanguinis was described in 1992 as a new genus and species of catalase-negative, facultatively anaerobic, non-motile, non-hemolytic, Gram-positive cocci (GPC) forming short chains or pairs by Collins, et al. [1] . Only 42 isolates from clinical specimens and 13 case reports about UTI, bacteremia, or meningitis have been reported (Table 1) . These reports suggest that G. sanguinis can colonize inguinal skin [2] and aged female patients with a history of cerebrovascular disease are susceptible to G. sanguinis. However, the epidemiology and the clinical significance of this pathogen remain largely unknown. G. sanguinis is an unusual pathogen that it could be misidentified or misdiagnosed with viridans streptococci (or may be overlooked) due to its colonial morphology [3] . We successfully identified the organism using the Rapid ID32 Strep system. We present the first case of an infective endocarditis by G. sanguinis following a UTI.
Case report
An 87 year-old Japanese woman was admitted to our hospital with recurrent episode of UTI, with a fever higher than 38.5°C for 5 days, and with hematuria despite taking oral levofloxacin 500 mg and acetaminophen 1200 mg daily. She had been bedridden at nursing home since a subarachnoid hemorrhage and surgical construction of ventriculo-peritoneal shunt, and she had gastrostomy 10 years ago. On examination, she had body temperature of 36.5°C, blood pressure 92/ 35 mmHg, pulse 84 bpm, respiratory rate 16 breaths/min, and pulse oxygen saturation 98% on room air. Physical examination showed Glasgow Coma Scale (GCS) of 7 (E2, V2, M3), inner lip bleeding, and systolic murmur at cardiac apex. Laboratory data at the admission was leucocyte count 35,600/mL, hemoglobin level 10.7 g/dL, platelet count 4.3000/mL, C-reactive protein 21.1 mg/dL, procalcitonin level 20.5 ng/mL, albumin 1.9 mg/dL, blood urea nitrogen 212 mg/dL, creatinine 3.9 ng/mL, uric acid 11.1 mg/dL, and lactate dehydrogenase 299 IU/L. Urine microscopy showed the presence of leukocytosis and numerous bacteria. Abdominal CT scans revealed bilateral hydronephrosis and hydroureters besides distended urinary bladder. After inserting urinary bladder catheter, pyuria and hematuria were obtained. Urinary gram stain showed GPC (1 + ) in pairs and short chains and Gram negative rods (GNR) (2+). She was diagnosed with infected hydronephrosis due to neurogenic bladder and started to receive ceftriaxone (CTRX) 2 g every 24 h empirically.
On day 3, her blood cultures from admission were growing aerobic, a-hemolytic GPC in short chains in 2 of 4 bottles (Fig. 1A, B) . On day 4, the isolates were identified as G. sanguinis with a high certainty (98.8%) by Rapid ID32 Strep (bioMerieux, Lyon, France). In order to double-check the results, we performed 16S rRNA sequencing because the species is rare and for confirmation of the diagnosis. Extended-spectrum b-lactamase producing Escherichia coli (ESBL-producing E. coli) simultaneously was observed in the two sets of blood culture bottles. G. sanguinis and ESBL-producing E.coli in her urine culture were also identified. She was diagnosed with bacteremia due to UTI caused by both of the organisms. The antimicrobial treatment was altered to meropenem 0.5 g every 12 h, for a 14-day course, considering (Table 2) by WalkAway 40 SI system (Beckman Coulter, California, USA) and her renal function test results. Urine culture obtained before treating with meropenem showed the growth of G. sanguinis again, but her repeated blood and urine cultures after treatment were negative. On day 6 of the treatment with meropenem, transthoracic echocardiography revealed a 3 mm (in diameter) vegetation ( Fig. 2A) on the mitral valve besides mild aortic, mitral and tricuspid regurgitation. Meeting with Duke's criteria (1 major and 3 minor criteria), she was eventually diagnosed with IE due to UTI-associated bacteremia. Her CT scans showed there was no abscess formation on the entire body. On day 10 of meropenem, a 2 mm vegetation on left coronary cusp of aortic valve was discovered by transesophageal echocardiography (TEE) (Fig. 2B) . We presumed that G. sanguinis caused the endocarditis and administered her a 2 week of ampicillin 2 g every 8 h intravenously after completion of the meropenem treatment. After the 2 weeks of ampicillin, no vegetation was detected on TEE. She showed improvement and was discharged from the hospital to a nursing facility. She was in the hospital for 40 days.
Discussion
We believe that this is the first case of having IE followed with UTI caused G. sanguinis complicated with ESBL-producing E.coli infection. G. sanguinis looks like viridans streptococci in Gram-stain morphology and colonial morphology including hemolysis pattern on sheep blood agar but has difference in not producing leucine aminopeptidase (LAP) and growth in the presence of 6.5% NaCl. Susceptibility to the thirdgeneration cephalosporins is also different: G. sanguinis is resistant while a-streptococcus is susceptible [3] . Although we successfully identified G. sanguinis by rapid ID32 Strep with a high certainty (98.8%), there are some past cases that failed G. sanguinis identification by the same methods [4] . There may be two reasons; one is that G. sanguinis shows various biochemical reaction depending on strain [5] and the other is that the data of G. sanguinis had not been collected on the database of the rapid ID32 Strep system until 2006. If rapid ID32 Strep fails to identify G. sanguinis, 16S rRNA sequencing is required. We additionally attempted Bruker matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) (Bruker Daltonics, Bremen, Germany) with MBT Compass software using MALDI Biotyper library version 5.0. The identification process suggested not G. sanguinis but G. sulfidifaciens with cutoff score of 1.97 (Table 3) . G. sulfidifaciens, first described in 2001 isolated only from animals, has 99.2% similarity in 16S rRNA gene sequencing to G. sanguinis [6] but is different in biochemical reaction. Although, Miller et al. succeeded to identify G. sanguinis with Bruker MALDI-TOF MS with MBT 6903 MSP library database [7] , MALDI-TOF MS is not so useful to identify the organism because there are only 3 G. sanguinis strains appeared in the database. An update of the database is needed.
In our case, both G. sanguinis and E. coli were found in blood culture when the patient was admitted. IE caused by E. coli is rare (< 1%) and G. sanguinis has been reported to be an opportunistic pathogen [8] [9] [10] . Patients diagnosed with E.colli IE are reported to be often diabetic with underlying heart disease or have prosthetic valves. Surgery is often necessary and the mortality rate is high (17%) [11] . Therefore, we speculated that IE caused by G. sanguinis followed a subacute clinical course, similar to viridans streptococcus, and her IE was caused by G. sanguinis. In order to verify our speculation, identifying G. sanguinis IE correctly with Rapid ID 32 Strep, collecting more cases of G. sanguinis IE, and then revealing clinical feature of G. sanguinis IE are required.
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